Opus Capital Group’s AstraZeneca AZN Stock Holding History

Opus Capital Group’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-3,553	Closed	-$293K	–	146
2019 Q2	$293K	Hold	3,553	–	–	0.09%	105
2019 Q1	$287K	Sell	3,553 -272	-7%	-$21.4K	0.08%	184
2018 Q4	$291K	Hold	3,825	–	–	0.06%	187
2018 Q3	$303K	Sell	3,825 -1,750	-31%	-$132K	0.07%	199
2018 Q2	$391K	Hold	5,575	–	–	0.1%	153
2018 Q1	$390K	Hold	5,575	–	–	0.1%	156
2017 Q4	$387K	Hold	5,575	–	–	0.09%	164
2017 Q3	$378K	Buy	5,575 +2,605	+88%	+$165K	0.09%	161
2017 Q2	$202K	Buy	+2,970	New	+$194K	0.04%	213
2016 Q1	–	Sell	-2,970	Closed	-$202K	–	194
2015 Q4	$202K	Buy	+2,970	New	+$195K	0.03%	249

Other funds holding AZN

Wellington Management Group

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Primecap Management

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Fidelity Investments

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Jennison Associates

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Capital International Investors

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Fisher Asset Management

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

T. Rowe Price Associates

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Bank of America

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Capital World Investors

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return